Nazila Bahmaie/LinkedIn
Jan 12, 2025, 12:39
Circulating Tumor Cells: Revolutionizing Cancer Management – International Society of Liquid Biopsy
International Society of Liquid Biopsy shared a post on X about a recent paper by Nazila Bahmaie
“ ISLB Research Highlight!
Circulating Tumor Cells (CTCs): Revolutionizing Cancer Management
Key Insights:
- CTCs enable phenotypic cell plasticity and tumor heterogeneity analysis.
- Serve as biomarkers for relapse, drug resistance, and therapy response.
- Potential use in personalized drug development and cell-based vaccines .
CTCs are paving the way for personalized and translational cancer medicine.
Discover More.”
“A revolutionary era in advancing precision immuno-oncology; role of circulating tumor cells”
Authors: Nazila Bahmaie, Ozen Ozensoy Guler,
More posts featuring International Society of Liquid Biopsy.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 12, 2025, 12:33
Jan 12, 2025, 12:30
Jan 12, 2025, 12:17
Jan 12, 2025, 11:50
Jan 12, 2025, 11:20
Jan 12, 2025, 11:19
Jan 12, 2025, 10:52